Valborg Gudmundsdottir
Overview
Explore the profile of Valborg Gudmundsdottir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
2870
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee S, Miller C, Bentley A, Brown M, Nagarajan P, Noordam R, et al.
Res Sq
. 2025 Mar;
PMID: 40034430
Background Gene-environment interactions may enhance our understanding of hypertension. Our previous study highlighted the importance of considering psychosocial factors in gene discovery for blood pressure (BP) but was limited in...
2.
Bortnick A, Austin T, Hamerton E, Gudmundsdottir V, Emilsson V, Jennings L, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e036336.
PMID: 40008515
Background: Calcific aortic valve disease (CAVD), and ensuing severe aortic stenosis (AS), is the foremost valvular disorder of aging, yet preventive therapies are lacking. A better understanding of the molecular...
3.
Bankier S, Gudmundsdottir V, Jonmundsson T, Bjarnadottir H, Loureiro J, Wang L, et al.
medRxiv
. 2025 Feb;
PMID: 39974043
Variations in blood protein levels have been associated with a broad spectrum of complex diseases, including atherosclerotic cardiovascular disease (ACVD). These associations highlight the intricate interplay between local (e.g., cardiovascular)...
4.
Frick E, Emilsson V, Jonmundsson T, Steindorsdottir A, Johnson E, Puerta R, et al.
Nat Aging
. 2024 Sep;
4(10):1509.
PMID: 39285016
No abstract available.
5.
Frick E, Emilsson V, Jonmundsson T, Steindorsdottir A, Johnson E, Puerta R, et al.
Nat Aging
. 2024 Aug;
4(10):1446-1464.
PMID: 39169269
A deeper understanding of the molecular processes underlying late-onset Alzheimer's disease (LOAD) could aid in biomarker and drug target discovery. Using high-throughput serum proteomics in the prospective population-based Age, Gene/Environment...
6.
Wang H, Nagarajan P, Winkler T, Bentley A, Miller C, Kraja A, et al.
Res Sq
. 2024 Jul;
PMID: 39070651
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we...
7.
Dammer E, Shantaraman A, Ping L, Duong D, Gerasimov E, Ravindran S, et al.
Sci Transl Med
. 2024 Jun;
16(753):eadn3504.
PMID: 38924431
Alzheimer's disease (AD) is currently defined by the aggregation of amyloid-β (Aβ) and tau proteins in the brain. Although biofluid biomarkers are available to measure Aβ and tau pathology, few...
8.
Nagarajan P, Winkler T, Bentley A, Miller C, Kraja A, Schwander K, et al.
medRxiv
. 2024 Mar;
PMID: 38496537
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we...
9.
Gudmundsdottir V, Frick E, Emilsson V, Jonmundsson T, Steindorsdottir A, Johnson E, et al.
Res Sq
. 2024 Jan;
PMID: 38260284
The current demand for early intervention, prevention, and treatment of late onset Alzheimer's disease (LOAD) warrants deeper understanding of the underlying molecular processes which could contribute to biomarker and drug...
10.
Axelsson G, Jonmundsson T, Woo Y, Frick E, Aspelund T, Loureiro J, et al.
Respir Res
. 2024 Jan;
25(1):44.
PMID: 38238732
Background: A decline in forced expiratory volume (FEV1) is a hallmark of respiratory diseases that are an important cause of morbidity among the elderly. While some data exist on biomarkers...